Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Activ Surgical lands FDA clearance for imaging device to enhance endoscope observations | ||
Fr | TransMedics' 'heart in a box' donor organ preservation system scores FDA panel backing | ||
Fr | Varian partners with Google Cloud to build AI models to streamline cancer treatment | ||
Fr | Biotech internships in a pandemic? Diversity-boosting Project Onramp adjusts to COVID-19, moves into Philadelphia, plots further expansion | ||
Fr | Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report | ||
Fr | Chutes & Ladders-3 weeks after leaving bluebird, CMO Davidson lands at Tessera | ||
Fr | Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg | ||
Fr | Provention warns FDA requests could delay diabetes approval | ||
Fr | Werewolf Therapeutics looks to make a killing in the public markets with a $100M IPO | ||
Do | Donisi scores FDA clearance for contactless AI system that spots changes in heart, breathing patterns | ||
Do | Abbott customizes TriClip heart valve system with upgraded EU approval | ||
Do | ValenzaBio picks up $70M, Pierre Fabre antibody for inflammatory eye disease | ||
Do | Liquid biopsy maker Nucleix rakes in $55M to develop blood tests to detect lung cancer early | ||
Do | Hologic inks its largest COVID-powered acquisition yet with $795M for test maker Mobidiag | ||
Do | Bannister joins SVB to help companies raise cash, access public markets | ||
Do | Lilly, AbCellera tout COVID-19 antibody combo potential as it loses strength against variants | ||
Do | CytoDyn's chief scientific officer Rahman quietly exits amid leronlimab limbo | ||
Do | Merck KGaA taps PRA Health's remote monitoring platform for its growth hormone treatment | ||
Do | Ventus raises $100M to pursue NLRP3, crack undruggable targets | ||
Do | Mission Bio, poised for growth, snags Thermo Fisher veteran Zhang as new CEO | ||
Mi | FDA grants first COVID-19 antibody green light for at-home, fingerprick blood test | ||
Mi | Dunking on COVID: NBA installs Clear Health Pass tech as arenas refill | ||
Mi | Digital diabetes treatment developer Better Therapeutics to go public in SPAC deal | ||
Mi | J&J Vision taps Menicon for contact lenses to slow childhood nearsightedness | ||
Mi | BMS, PsiOxus add an asset to Opdivo-oncolytic virus combo deal |